Lord's Mark Industries outlines strategic expansion across global healthcare, advanced diagnostics & oncology; targets ₹1,550 Crore revenue in FY2027

In a strategic shift, Lord's Mark Industries is set to launch an extensive healthcare expansion alongside a business demerger. This initiative will prioritize advancements in diagnostics, oncology, and cutting-edge medical devices, bringing CAR-T cell therapy and specialized oncology hospitals to a wider Indian demographic. The company's international vision includes launching subsidiaries in the UK and Switzerland, aiming to bolster its diagnostic capabilities and strengthen its healthcare service value chain.